TOP > 外国特許検索 > BIOMARKER FOR FIBROSIS EVALUATION, EVALUATION METHOD FOR FIBROSIS, AND BACTERIAL CULTURE MEDIUM FOR EVALUATION

BIOMARKER FOR FIBROSIS EVALUATION, EVALUATION METHOD FOR FIBROSIS, AND BACTERIAL CULTURE MEDIUM FOR EVALUATION NEW

外国特許コード F170009239
整理番号 (S2016-0508-N0)
掲載日 2017年9月21日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2017JP008579
国際公開番号 WO 2017150720
国際出願日 平成29年3月3日(2017.3.3)
国際公開日 平成29年9月8日(2017.9.8)
優先権データ
  • 特願2016-041740 (2016.3.4) JP
発明の名称 (英語) BIOMARKER FOR FIBROSIS EVALUATION, EVALUATION METHOD FOR FIBROSIS, AND BACTERIAL CULTURE MEDIUM FOR EVALUATION NEW
発明の概要(英語) [Problem] To provide an evaluation method for fibrosis and a biomarker for fibrosis evaluation. [Solution] A biomarker for fibrosis evaluation, the biomarker being for detection in biological samples obtained from test animals and including at least one type of bacteria selected from the group the consists of Christensenella , Clostridium , Halomonas , and Shewanella . The fibrosis may include, for example, pulmonary fibrosis (including IPF), renal fibrosis, or the like.
特許請求の範囲(英語) [claim1]
1. Being the bio marker for tissue symptom appraisal which is detected to the organism sample which is obtained from the suffering animal, kurisutensenera (Christensenella), kurosutorijiumu (Clostridium), haromonasu (Halomonas) and shiyuwanera (Shewanella) the bio marker for tissue symptom appraisal which at least includes a kind of from the group which consists of is selected bacterium.
[claim2]
2. The aforementioned organism sample, in the claim 1 which at least is one which is selected from the group which consists of the clearing solvent of the saliva, the blood and the organizational surface and the organization which is cut off the bio marker for tissue symptom appraisal of statement.
[claim3]
3. The aforementioned tissue symptom, the lung tissue symptom and the kidney tissue symptom, in the claim 1 which at least is one which is selected from the group which consists of or 2 the bio marker for tissue symptom appraisal of statement.
[claim4]
4. Concerning the organism sample which is obtained from the suffering animal, kurisutensenera (Christensenella), kurosutorijiumu (Clostridium), haromonasu (Halomonas) and shiyuwanera (Shewanella) evaluation method of the tissue symptom which at least detects a kind of from the group which consists of is selected bacterium.
[claim5]
5. The aforementioned detection, in the claim 4 which is something which detects the nuclear acid which is derived from the bacterium evaluation method of the tissue symptom of statement.
[claim6]
6. The bacterial nutrient medium for tissue symptom appraisal for bacterial group which at least includes a kind of from the group which (1) haromonasu (Halomonas) it includes, (2) kurisutensenera (Christensenella), kurosutorijiumu (Clostridium) and shiyuwanera (Shewanella) consists of is selected bacterium.
[claim7]
7. Being the nutrient medium for the bacterium of statement in claim 6, the bacterial nutrient medium for tissue symptom appraisal which includes with carbon source and nitrogen source and the mineral and the sodium chloride of 0.34M-5M.
[claim8]
8. The freezing bacterium for tissue symptom appraisal which freezes the bacterial group which at least includes a kind of from the group which (1) haromonasu (Halomonas) it includes, (2) kurisutensenera (Christensenella), kurosutorijiumu (Clostridium) and shiyuwanera (Shewanella) consists of is selected bacterium.
[claim9]
9. The dry bacterium for tissue symptom appraisal which dries the bacterial group which at least includes a kind of from the group which (1) haromonasu (Halomonas) it includes, (2) kurisutensenera (Christensenella), kurosutorijiumu (Clostridium) and shiyuwanera (Shewanella) consists of is selected bacterium.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • MIE UNIVERSITY
  • 発明者(英語)
  • GABAZZA ESTEBAN
  • GABAZZA CORINA
  • CANN ISAAC
国際特許分類(IPC)
指定国 (WO2017150720)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
さらに詳しい情報をご要望の方は、下記「問合せ先」までお問い合わせください。未公開情報等の交換をおこなう場合は秘密保持契約を締結しての面談等にて対応しております。

PAGE TOP

close
close
close
close
close
close